Trial Profile
Phase II trial to evaluate SGN CD19A along with R-ICE chemotherapy in patients with diffuse large B-cell lymphoma
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2021
Price :
$35
*
At a glance
- Drugs Denintuzumab mafodotin (Primary) ; Carboplatin; Etoposide; Ifosfamide; Rituximab
- Indications B-cell lymphoma
- Focus Therapeutic Use
- Sponsors Seagen
- 10 Feb 2015 Seattle Genetics plans to initiate this study in 2015.
- 27 Jan 2015 New trial record